| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.087 | 0.06 |